Vein thrombus model and method for manufacturing same, and medical instrument testing device and thrombus removal performance evaluation method using vein thrombus model

A venous thrombus model and test device simulate human venous thrombosis using a thrombin-coated resin container and auxiliary unit, allowing for the evaluation of thrombus removal performance in a non-clinical setting, addressing the limitations of existing methods and facilitating the development of treatment devices and agents for the Japanese market.

WO2024232073A1PCT designated stage expired Publication Date: 2024-11-14WASEDA UNIV
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2023/017698
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-11
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

Current methods for evaluating the effectiveness and thrombus removal performance of deep vein thrombosis treatment devices are limited by the difference in thrombolytic agents approved in Europe and the US compared to Japan, making it difficult to conduct clinical trials for these devices in Japan, and there is a need for a simulation model that mimics human venous thrombosis for non-clinical testing.

Method used

A venous thrombus model is created using a resin container with a thrombin-coated inner wall, where human blood is filled and rotated to form a thrombus that adheres to the container, and a test device is developed with an auxiliary unit for simulating human venous thrombosis, including an insertion section, internal pressure adjustment, and temperature maintenance, allowing for the evaluation of thrombus removal performance in a non-clinical environment.

Benefits of technology

This approach enables easy and effective evaluation of venous thrombosis treatment devices in an ex-vivo environment, similar to actual clinical trials, facilitating the development of treatment devices and thrombolytic agents suited for the Japanese market.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2023017698_14112024_PF_FP_ABST
    Figure JP2023017698_14112024_PF_FP_ABST
Patent Text Reader

Abstract

A testing device 10 of the present invention includes: a vein thrombus model 11 simulating a vein thrombus occurring in the human body; and an accompanying unit 12 that accompanies the vein thrombus model 11. The vein thrombus model 11 comprises a resin tubular container 14 the interior of which is visible from the outside, and a thrombus 15 filled in the tubular container 14. The tubular container 14 has a silicone coating on the inner wall, to which thrombin is further applied. The thrombus 15 is placed in a state of being adhered to the inner wall of the tubular container 14. The accompanying unit 12 includes: a catheter insertion part 22 for allowing a medical instrument to access the vein thrombus model 11; an internal pressure adjustment part 23 for mitigating internal pressure changes in the vein thrombus model 11; and a thermostatic tank 25 for maintaining the vein thrombus model 11 at a predetermined temperature.
Need to check novelty before this filing date? Find Prior Art

Description

Venous thrombosis model and its manufacturing method, and medical device test device and thrombus removal performance evaluation method using a venous thrombosis model

[0001] The present invention relates to a venous thrombosis model and a method for producing the same, as well as a testing device for medical devices and a method for evaluating thrombus removal performance using the venous thrombosis model.

[0002] Deep vein thrombosis (DVT), a vascular disease characterized by the formation of blood clots in veins deep below the deep fascia, is a common vascular disease. Treatments for DVT include anticoagulant therapy to prevent new clot formation, thrombolytic therapy to dissolve existing clots, and catheter-based interventions. One type of catheter-based intervention involves the use of a catheter-like device to aspirate and remove DVT, injecting a thrombolytic agent directly onto the clot and then aspirating it (pharmacomechanical catheter-based thrombolysis). Other catheter-based interventions include those that entrap and remove DVTs, and those that aspirate clots using negative pressure. Quantitative evaluation of the efficacy and thrombus removal performance of these interventions has only been conducted in Europe and the United States. Because approved thrombolytic agents differ between Europe and the United States and Japan, quantitative evaluation of the therapeutic effects of these interventions in the Japanese pharmaceutical environment is crucial for the widespread adoption of these interventions within Japan. This treatment is expected to contribute to improving the prognosis of patients with severe deep vein thrombosis. Therefore, there is a need for the development of treatment devices suited to the physique and blood properties of Japanese people, as well as for performance evaluation of treatment devices using thrombolytic agents available in Japan. However, when thrombolytic agents approved in Europe and the United States differ from those approved in Japan, it is difficult to evaluate such treatment devices in clinical trials. Therefore, the inventors believe that the development of in vitro testing methods outside the body, rather than clinical trials, is important. Therefore, they are conducting intensive research into the development of devices and techniques for evaluating the performance of such treatment devices in non-clinical environments using simulated venous thrombosis models simulating deep vein thrombosis and other conditions. Therefore, a model simulating venous thrombosis that occurs in humans is required to conduct non-clinical clinical trials of such treatment devices.

[0003] Patent Document 1 discloses a method for producing a venous thrombosis model by irradiating light onto veins around a ligated vein in a non-human mammal, with the aim of elucidating the mechanism of venous thrombosis.

[0004] Japanese Patent Application Laid-Open No. 2020-160058

[0005] However, the venous thrombosis model of Patent Document 1 cannot be applied to non-clinical trials of the above-mentioned deep vein thrombosis treatment device, etc. In other words, when evaluating the performance of this treatment device, as described above, a thrombosis model that simulates human venous thrombosis is important because of the influence of the pharmacological effect of the thrombolytic agent. Therefore, as a result of intensive research, the present inventors have developed a method for artificially creating a model that simulates venous thrombosis that occurs in humans using human venous blood.

[0006] An object of the present invention is to provide a venous thrombosis model and a method for manufacturing the same that enable testing and evaluation of venous thrombosis treatment devices and the like in a non-clinical environment using a model that simulates human venous thrombosis, as well as a testing device for medical devices and a method for evaluating thrombus removal performance that use the venous thrombosis model.

[0007] In order to achieve the above-mentioned object, the present invention provides a venous thrombosis model comprising a resin container and a thrombus filled inside the container, wherein the inner wall of the container is coated with a material that binds to thrombin through hydrophobic interaction, and the thrombin is then applied to the container, and the thrombus is placed in a state where it is adhered to the inner wall of the container.

[0008] The present invention also provides a method for producing a venous thrombosis model that simulates venous thrombosis that occurs in the human body, which employs a technique in which the inner wall of a cylindrical resin container is coated with a material that binds to thrombin through hydrophobic interaction, the thrombin is applied to the surface, and then blood is filled into the cylindrical container and rotated around the axis to stir, thereby forming a thrombus that adheres to the inner wall of the cylindrical container.

[0009] Furthermore, the present invention provides a testing device for evaluating the performance of a medical device using the venous thrombosis model, which includes an auxiliary unit attached to the venous thrombosis model, the auxiliary unit comprising: an insertion section for allowing the medical device to access the venous thrombosis model; an internal pressure adjustment section for mitigating changes in the internal pressure of the venous thrombosis model; and a temperature maintenance section for maintaining the venous thrombosis model at a predetermined temperature.

[0010] The present invention also provides a method for evaluating the thrombus removal performance of a therapeutic device using the testing device, which involves inserting a catheter through an inserter and placing the tip end of the catheter in the venous thrombus model, which is maintained at a predetermined temperature by the temperature maintaining unit, measuring the mass of the thrombus present in the venous thrombus model before and after use of the therapeutic device, which is expected in clinical practice, and understanding the changes by calculating the rate of change, etc., thereby evaluating the thrombus removal performance of the therapeutic device.

[0011] According to the present invention, it becomes possible to perform comparatively easy evaluation of treatment of venous thrombosis treatment devices and the like under ex-vivo conditions similar to those of actual clinical trials.

[0012] It is a perspective view showing a test device for a medical device according to the present embodiment. It is a front view showing a venous thrombosis model. It is a schematic cross-sectional view showing a part of the venous thrombosis model and a catheter insertion part.

[0013] Hereinafter, an embodiment of the present invention will be described with reference to the drawings.

[0014] FIG. 1 is a perspective view showing a schematic diagram of a medical device testing apparatus according to the present embodiment. In this figure, the testing apparatus 10 is an apparatus used, for example, to evaluate the performance of medical devices used to treat venous thrombosis in a human body in an ex-vivo environment. The testing apparatus 10 includes a venous thrombosis model 11 that simulates a venous thrombosis that occurs in a human body, and an auxiliary unit 12 associated with the venous thrombosis model 11. While not particularly limited, the testing apparatus 10 according to the present embodiment is configured to perform a test to evaluate the performance of a known catheter-based medical device that sprays a thrombolytic agent directly onto a thrombus and then aspirates the thrombus.

[0015] As shown in FIG. 2, the venous thrombosis model 11 is a model that simulates venous thrombosis in deep vein thrombosis, a condition in which a thrombus forms in a vein running deeper than the deep fascia of the human body, and is composed of a cylindrical container 14 (container) made of a translucent resin whose interior can be seen from the outside, and a thrombus 15 that is filled inside the cylindrical container 14 and artificially produced by a method described below.

[0016] The cylindrical container 14 is a straight tube made of acrylic. A silicone coating 17 is applied to the inner wall of the cylindrical container 14, and thrombin, a coagulation factor, is applied to the surface (inner surface) of the silicone coating 17. The dimensions and shape of the cylindrical container 14 are not particularly limited, but varying these dimensions and shape makes it possible to simulate veins with any anatomical characteristics. For example, a cylindrical container 14 for the iliac / femoral vein may have an inner diameter of approximately 12 mm and a length of approximately 200 mm. While the silicone coating 17 is applied to the inner wall of the cylindrical container 14 in this embodiment, the present invention is not limited to silicone. To attach thrombin to the cylindrical container 14, any material that can bind to thrombin through hydrophobic interaction and can be used as a coating for the cylindrical container 14 may also be used.

[0017] The venous thrombosis model 11 is produced, for example, as follows.

[0018] First, to simulate deep vein thrombosis adsorbed to the inner wall of a human blood vessel, an acrylic pipe with an inner diameter of 12 mm and a length of 210 mm was prepared as the cylindrical container 14. A silicone coating with hydrophobic interaction with thrombin was applied to the inner wall of the acrylic pipe to a thickness of 0.24 mm within a range of ±0.01 mm. The silicone coating procedure was as follows: (1) Material A (KE-1603-A: manufactured by Shin-Etsu Chemical Co., Ltd.), Material B (KE-1603-B: manufactured by Shin-Etsu Chemical Co., Ltd.), and silicone oil were mixed in a ratio of 5:5:3, and the mixture was then passed through a vacuum degassing device to prepare the silicone for application. (2) The silicone for application was poured into the acrylic pipe. (3) A leveling rod was run back and forth within the acrylic pipe to remove excess silicone. (4) The acrylic pipe was left standing vertically for 4.5 to 5.5 hours.

[0019] Thereafter, the coagulation factor thrombin (10,000 units) is applied to the surface of the silicone coated inner wall of the cylindrical container 14 .

[0020] The thrombus 15 is prepared from human blood (whole blood) collected from the same individual according to the following procedure, and is placed in a state of being adhered to the inner wall of the cylindrical container 14. Note that porcine blood or the like can also be used as the blood used to prepare the thrombus 15, as long as it produces the same effect.

[0021] First, a highly antithrombotic blood storage pack coated with MPC polymer (2-methacryloyloxyethyl phosphorylcholine polymer) is prepared, and whole blood after collection is stored in the blood storage pack.

[0022] Next, fibrinogen is added to the whole blood, and the whole blood is stirred for approximately 5 minutes at a temperature of approximately 37°C. The amount of fibrinogen used is 370 mg per 30 ml of whole blood. This amount was determined experimentally by the inventors based on clinical data on the residual thrombus mass ratio (60%) after pharmacomechanical catheter-based thrombolysis in patients with deep vein thrombosis, and reflects the mechanical properties of the thrombus to which the catheter-based treatment device is applied. The hardness of the thrombus can be altered by changing the amount of fibrinogen added.

[0023] Then, the inside of the cylindrical container 14, with thrombin applied to the inner wall as described above, is filled with whole blood to which the fibrinogen has been added, and the cylindrical container 14 filled with the blood is rotated and stirred around its axis at about 10 rpm in an environment with a temperature of about 37 degrees so that the blood cell components are uniformly distributed, thereby generating a thrombus 15 that adheres to the inner wall of the cylindrical container 14 and fills the internal space.

[0024] More specifically, the thrombus 15 is produced in the following procedure.

[0025] (1) Blood from a healthy human volunteer is collected by head-to-head blood removal. 200-250 mL of blood is collected into a 400 mL blood collection bag whose inner surface has been pre-coated with MPC polymer. All equipment is sterilized, and the procedure is performed in a clean environment. (2) 370 mg of fibrinogen is added to 30 mL of human blood, and the bag is stirred for 4-6 minutes at a temperature of 35-39°C, and blood properties are measured. (3) Blood containing fibrinogen is collected using a syringe pre-filled with 14 μL of 0.25 mol / L calcium chloride per mL of healthy human blood. The blood is then filled into an acrylic pipe (cylindrical container 14) whose inner wall has been coated with thrombin as described above. Silicone stoppers 19 are then attached to the open ends of both ends of the acrylic pipe. (4) Then, the acrylic pipe filled with blood containing fibrinogen is rotated on the mix rotor at a speed of 9 to 11 rpm to generate a thrombus 15. At this time, the mix rotor is placed in an incubator set at a temperature of 35 to 39 degrees.

[0026] The artificially obtained thrombus 15 is attached to the cylindrical container 14 in the same manner as a venous thrombus attached to the inner wall of a blood vessel in the human body, and as a result of the inventors' testing and research, the thrombolytic effect of each thrombolytic agent approved in Europe, the United States, and Japan has been confirmed.

[0027] As shown in FIG. 1 , the auxiliary unit 12 includes acrylic connecting pipes 21 connected to both ends of the venous thrombosis model 11, a catheter insertion section 22 (insertion section) connected to one of the connecting pipes 21 (the right side in the figure) for inserting a catheter C of the treatment device into the connecting pipe 21 to access the venous thrombosis model 11, an internal pressure adjustment section 23 connected to the connecting pipe 21 and mitigating changes in the internal pressure of the venous thrombosis model 11, a fixing section 24 for fixing the venous thrombosis model 11, and a thermostatic bath 25 as a temperature maintaining section for maintaining the test environment at a predetermined temperature.

[0028] The connecting pipeline 21 is connected via connectors 27 to both open ends of the cylindrical container 14 from which the silicone stopper 19 (see Figure 2) has been removed, and the internal space of the connecting pipeline 21 is connected to the internal space of the cylindrical container 14.

[0029] Each of the connecting pipes 21 on both ends of the venous thrombosis model 11 comprises an L-shaped first bent portion 29 that connects to the cylindrical container 14 and bends upward midway, an L-shaped second bent portion 30 that is positioned relative to the first bent portion 29, and a straight pipe-like connecting portion 31 that connects the upper portions of the first and second bent portions 29, 30. The first bent portion 29 is filled with physiological saline S up to the middle of the standing portion, preventing air bubbles from entering the venous thrombosis model 11 connected to the first bent portion 29.

[0030] As shown in Figure 3, the catheter insertion section 22 is composed of a tube 34 connected to the first bend 29 on one side, an introducer 35 of known structure that is inserted and fixed in the tube 34 and is positioned so that its tip extends to the inside of the cylindrical container 14, and an inserter 36 that serves as an insertion port for the catheter into the introducer 35.

[0031] The introducer 35 has a shape in which the diameter is large at the catheter insertion port side, and the diameter is reduced at a tapered portion midway, and the introducer 35 extends in a state of being small at the tip side, and a through space is formed between them. Therefore, the tip side of the catheter inserted from the inserter 36 can pass through the through space and access the thrombus 15 inside the cylindrical container 14.

[0032] The inserter 36 is connected to the inlet side of the introducer 35 and is structured to allow the catheter to access the inlet side of the introducer 35 without allowing the liquid that flows back into the connecting pipeline 21 when a drug is sprayed from the tip side of the catheter to leak out.

[0033] The inserter 36 is composed of a main body 38 connected to the introducer 35 and a handle 39 attached movably to the main body 38 so as to move towards and away from the main body 38 .

[0034] 3, where the catheter is inserted, to the through-space of the introducer 35. This space 38S is designed to allow the catheter to pass through, with the introducer 35 side being the small-diameter portion and the handle 39 side being the large-diameter portion. The distal end of the handle 39 is threadedly fitted into the large-diameter portion with an elastically deformable seal member 42 interposed therebetween.

[0035] The sealing member 42 is made of silicone and is formed in a ring or cylindrical shape, with a central hole through which a catheter can pass.

[0036] A space 39S is formed inside the handle 39, through which a catheter inserted from the open portion at the right end in Fig. 3 can pass, and this space 39S is connected to the hole in the seal member 42. Therefore, with the catheter set so that it passes from space 39S through space 38S in the main body 38 and its tip side reaches the venous thrombosis model 11, when the screw of the handle 39 is turned and the handle 39 is brought closer to the main body 38 in a direction that reduces the volume of the large-diameter portion of space 38S, the seal member 42 is compressed by elastic deformation, and the gap between space 38S, including its central hole, and the outer peripheral surface of the catheter is closed, preventing leakage of liquid from the introducer 35 side to the outside.

[0037] 1, the internal pressure adjusting section 23 is composed of a reservoir-like tube connected to the lower end side of the second bend section 30 of each connecting pipe line 21. This reservoir-like tube contains air at a predetermined pressure in order to mitigate changes in the internal pressure of the venous thrombosis model 11 caused by operations such as drug injection and thrombus suction using a catheter.

[0038] The fixing part 24 is made of a bottomed frame body that is open at the top, and both sides of the venous thrombosis model 11 are immovably attached by fixing devices (not shown) that are fixed to the bottom of the fixing part 24 .

[0039] The thermostatic bath 25 is box-shaped and open at the top, and the venous thrombosis model 11 and the auxiliary unit 12 are placed inside and appropriately fixed. The thermostatic bath 25 contains physiological saline solution S controlled to a predetermined temperature (approximately 37°C), and is designed to maintain the temperature of the venous thrombosis model 11 and its surroundings constant. The inserter 36 protrudes outside the thermostatic bath 25. Note that the temperature maintaining unit that maintains the venous thrombosis model 11 at a predetermined temperature is not limited to the thermostatic bath 25 configured in this embodiment, as long as it performs the same function.

[0040] Next, a method for evaluating the thrombus removal performance of the catheter-based treatment device described above using the test device 10 will be described.

[0041] First, the venous thrombosis model 11 is attached to the fixing part 24 and placed in the thermostatic bath 25 so that the temperature is approximately 37°C. Then, the connecting conduits 21 on both ends of the venous thrombosis model 11 are filled with physiological saline, and the catheter C is inserted through the inserter 36, with its tip placed in the venous thrombosis model 11. Then, in accordance with the expected clinical usage of the treatment device, a thrombolytic agent is injected onto the thrombus 15 and a thrombus removal operation is performed. Finally, the venous thrombosis model 11 is detached from the fixing part 24, and the mass of the thrombus 15 present before and after use of the treatment device is measured. The rate of change (rate of change in residual thrombus mass) is calculated to understand the change in the thrombus 15, thereby evaluating the thrombus removal performance of the treatment device.

[0042] The test device 10 of the present invention is not limited to the testing and evaluation of the catheter-based treatment device for deep vein thrombosis in the above embodiment, but can also be applied to the performance evaluation of other devices used in thrombus treatment, such as other thrombus suction and removal devices and devices that entangle thrombus and remove it via a catheter.

[0043] Furthermore, the configuration of each part of the device in the present invention is not limited to the illustrated configuration example, and various modifications are possible as long as they provide substantially the same effect.

[0044] REFERENCE SIGNS LIST 10 Test device 11 Venous thrombosis model 12 Auxiliary unit 14 Cylindrical container (container) 15 Thrombus 17 Silicone coating 21 Connecting conduit 22 Catheter insertion part (insertion part) 23 Internal pressure adjusting part 25 Thermostatic bath (temperature maintaining part) 35 Introducer 36 Inserter 38 Main body 38S Space 39 Handle 42 Sealing member

Claims

1. A venous thrombosis model comprising a resin container and a thrombus filled inside the container, wherein the inner wall of the container is coated with a material that binds to thrombin through hydrophobic interaction, and the thrombin is then applied to the inner wall of the container, and the thrombus is disposed in a state where it is adhered to the inner wall of the container.

2. The venous thrombosis model according to claim 1, characterized in that the container has a structure that allows the inside to be visually observed from the outside.

3. The venous thrombosis model according to claim 1, characterized in that the material is silicone.

4. The venous thrombosis model according to claim 1, characterized in that the thrombus is made of blood to which fibrinogen has been added.

5. A method for producing a venous thrombosis model that mimics venous thrombosis that occurs in the human body, comprising coating the inner wall of a resin cylindrical container with a material that binds to thrombin through hydrophobic interaction, applying the thrombin to the surface, filling the cylindrical container with blood and rotating and stirring the container around its axis, thereby forming a thrombus that adheres to the inner wall of the cylindrical container.

6. The method for producing a venous thrombosis model according to claim 5, wherein fibrinogen is added to the blood before the rotary stirring.

7. A testing device for evaluating the performance of a medical device using the venous thrombosis model according to claim 1, comprising an auxiliary unit attached to said venous thrombosis model, said auxiliary unit comprising: an insertion section for allowing said medical device to access said venous thrombosis model; an internal pressure adjusting section for mitigating changes in internal pressure of said venous thrombosis model; and a temperature maintaining section for maintaining said venous thrombosis model at a predetermined temperature.

8. A testing device for a medical device using a venous thrombosis model as described in claim 7, characterized in that the internal pressure adjustment unit is composed of a reservoir-like tube connected to the venous thrombosis model and which buffers changes in the internal pressure of the venous thrombosis model when the medical device is operated within the venous thrombosis model.

9. A testing device for medical devices using a venous thrombosis model as described in claim 7, characterized in that the auxiliary unit further comprises connecting pipes connected to both ends of the venous thrombosis model, the inside of which is filled with physiological saline.

10. A test device for a medical device using a venous thrombosis model as described in claim 7, characterized in that the medical device is a treatment device that removes thrombi using a catheter to treat venous thrombosis, the insertion section comprises an introducer arranged so that its tip extends to the venous thrombosis model, and an inserter that serves as an insertion port for the catheter into the introducer, the inserter being composed of a main body connected to the introducer and a handle attached to the main body so as to be movable toward and away from the main body, a space is formed inside the main body through which the catheter can pass when accessing the venous thrombosis model with the catheter, and an elastically deformable sealing material is disposed within the space, and the sealing material is elastically deformed by bringing the handle close to the main body, thereby closing a gap between the outer peripheral surface of the catheter and the space, thereby forming a structure that can prevent liquid from leaking from the introducer side to the outside.

11. A method for evaluating the thrombus removal performance of the treatment device using the test device described in claim 10, comprising inserting the catheter through the inserter and placing the tip side of the catheter in the venous thrombus model maintained at a predetermined temperature by the temperature maintaining unit, measuring the mass of the thrombus present in the venous thrombus model before and after use of the treatment device anticipated in clinical practice, and evaluating the thrombus removal performance of the treatment device by grasping the changing conditions by calculating the rate of change, etc.

Citation Information

Patent Citations

  • Artificial coronary artery, coronary artery stunt performance evaluation simulator

    JP2000342692A

  • Coronary artery circulation simulation device

    JP2016126258A

  • Biological model and manufacturing method

    JP2017146415A

  • Vascular lesion model and method of manufacturing the same

    JP2021067796A

  • Vascular lesion model

    WO2023017600A1